Loading organizations...
Founded in 2013 as a Massachusetts Institute of Technology spinout by Timothy Swager and Joseph Walish, C2Sense is a Watertown, Massachusetts-based technology company that recently rebranded as Hyperion Biosystems. The enterprise develops advanced optical sensing systems utilizing fluorescence, computer vision, and physics-based algorithms to create low-cost diagnostic devices and anti-counterfeiting solutions. Serving the medical diagnostics, pharmaceutical, and supply chain industries, the startup operates under Chief Executive Officer Jason Cox with approximately fifteen employees and thirteen filed patents. The business has successfully raised a total of 11,700,000 dollars in grant and equity funding, which includes a seed round of 3,200,000 dollars backed by the early investor Newlin. To further support the commercialization of its rapid diagnostic assays and optical readers, the company recently expanded its leadership team by appointing Kevin Ban as a strategic advisor.
C2Sense has raised $3.2M across 1 funding round.
C2Sense has raised $3.2M in total across 1 funding round.
C2Sense has raised $3.2M in total across 1 funding round.
C2Sense's investors include Reed Sturtevant, Boston Millennia Partners, Breakout Labs, Castor Ventures, Cranberry Capital, Hiroshi Nakano, William Newlin, Propel(x), TLP Investment Partners.
C2Sense has raised $3.2M across 1 funding round. Most recently, it raised $3.2M Seed in September 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 19, 2017 | $3.2M Seed | Reed Sturtevant | Boston Millennia Partners, Breakout Labs, Castor Ventures, Cranberry Capital, Hiroshi Nakano, William Newlin, Propel(x), TLP Investment Partners | Announced |
